GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.

Cervical cancer, a leading cause of cancer deaths among women, can be significantly reduced through HPV vaccination and ...

The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

The UK Health Security Agency (UKHSA) is strongly encouraging young people to receive the HPV vaccine when it's offered in ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

The life-saving HPV vaccine, which is offered to school aged children in years 8 to 11, can protect people against a number ...

The change to a single-dose HPV vaccine has led to more girls in Lambeth receiving the jab in the last school year, new ...

Doctors in Namibia are advocating greater access to healthcare and the HPV vaccine to reduce the prevalence of the disease ...

TWO women lose their lives to cervical cancer every day in the UK. Like all types of the disease, the earlier it’s caught, the better. Around 95 per cent of those diagnosed at stage 1 will ...

On the occasion of Cervical cancer awareness month Adarsha Hospital, Udupi, is organizing a cervical cancer screening camp on ...

Dr. Theresa Byrd, dean of UT Tyler School of Health Professions, said with the HPV vaccine is available, it is the best way to prevent cervical cancer.